Biomarkers, including transaldolase, aflatoxin B1 aldehyde reductase, and gamma-glutamylcysteine synthetase, were identified as upregulated genes in hepatocellular carcinoma (HCC) [46]. This evidence concerns the gene TALDO1 and hepatocellular carcinoma.